Invasive Fungal Infection clinical trials

Explore recruiting invasive fungal infection clinical trials.

Recruiting invasive fungal infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Invasive Fungal Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Rezafungin plasma concentrations in patients with or without extracorporal treatments (ECMO ± RRT)

Austria

Phase III and phase IV (Integrated) EU CTIS Study details

Study of posaconazole prophylaxis in patients receiving hematopoietic stem cell allograft (allo-HSC) at high risk of invasive fungal infection (IFI): POSALLO study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

EFRAIM II _ Empirical steroids and/or antifungals in immunocompromised patients with acute respiratory failure from undetermined etiology: a multicenter double-blind randomized controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1, Multicentre, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single IV Dose of Rezafungin Acetate in Paediatric Subjects from Birth to <18 Years of Age, Receiving Systemic Antifungals as Prophylaxis for Invasive Fungal Infection or to Treat a Suspected or Confirmed Fungal Infection

Germany, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Randomized, placebo-controlled, double blind, multi-centre Phase IIb stuDy to evaluate the efficacy and safety of HepaStem in patients with Acute on Chronic Liver Failure (ACLF) – DHELIVER

Denmark, Poland, Bulgaria, Netherlands, Slovakia, Latvia +8 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) trial

Denmark, Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Invasive Fungal Infection trials by city

Invasive Fungal Infection in Toronto Invasive Fungal Infection in Vancouver Invasive Fungal Infection in Montreal Invasive Fungal Infection in Calgary Invasive Fungal Infection in Edmonton Invasive Fungal Infection in Ottawa Invasive Fungal Infection in Winnipeg Invasive Fungal Infection in Quebec City Invasive Fungal Infection in Hamilton Invasive Fungal Infection in Kitchener Invasive Fungal Infection in London Invasive Fungal Infection in Halifax Invasive Fungal Infection in New York Invasive Fungal Infection in Los Angeles Invasive Fungal Infection in Chicago Invasive Fungal Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease